Their pharma products have only hit the market in Q4 of FY19... What track record of them selling these products are you referring to?
You do realise our products are only accessed through specialist access, so patients would need to get prescriptions directly from a relevant doctor. And if you read the announcement - "Mexacare provides the sales, marketing and logistics for diagnostic devices and complementary medicalproducts to pharmacies, allied health practitioners, labs, hospitals and doctors." To paraphrase, they will handle the logistic of getting the product to the consumer and provide services not just to pharmacies, but to doctors directly.
Mexacare also has KPIs as part of the agreements - number of doctors briefed,quantity of product to be ordered, number of prescriptions issued and processed. So your comments around customers having to travel over "50kms" to access the our products is not relevant and unsubstantiated.
- Forums
- ASX - By Stock
- RGT
- Ann: MGC Research- Effectiveness of Cannabinoids on Brain Cancers
Ann: MGC Research- Effectiveness of Cannabinoids on Brain Cancers, page-56
Featured News
Add RGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.5¢ |
Change
0.010(3.64%) |
Mkt cap ! $15.46M |
Open | High | Low | Value | Volume |
26.0¢ | 28.5¢ | 26.0¢ | $264 | 932 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6148 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 1501 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6000 | 0.255 |
2 | 4408 | 0.250 |
1 | 20000 | 0.240 |
1 | 2200 | 0.230 |
1 | 16950 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 1501 | 1 |
0.295 | 34 | 1 |
0.300 | 50 | 1 |
0.305 | 2073 | 2 |
0.310 | 50 | 1 |
Last trade - 14.18pm 15/11/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online